Showing results (291-300 of 446) with videos related to

Sort By:
Pageof 45
International Journal of Environmental Research and Public Health|December 1, 2019
Prognostic Value of CD1B in Localised Prostate CancerCheng-Hsueh Lee, Lih-Chyang Chen, Chia-Cheng Yu, et al.
Cancers|May 30, 2020
Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese MenChien-Chih Ke, Lih-Chyang Chen, Chia-Cheng Yu, et al.
Plos One|December 6, 2011
New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in TaiwanJi-Rong Yang, Yuan-Pin Huang, Feng-Yee Chang, et al.
Toxicology and Applied Pharmacology|October 11, 2011
The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure areaChao-Yuan Huang, Chien-Tien Su, Jan-Show Chu, et al.
European Urology|July 1, 2011
SRD5A polymorphisms and biochemical failure after radical prostatectomyEtienne Audet-Walsh, Judith Bellemare, Geneviève Nadeau, et al.
The Kaohsiung Journal of Medical Sciences|January 15, 2008
Laparoscopic partial nephrectomy: the effect of preoperative tumor embolizationChing-Chia Li, Yii-Her Chou, Wen-Jeng Wu, et al.
The International Journal of Biological Markers|September 30, 2009
Downregulation of ABCD1 in human renal cell carcinomaTzyh-Chyuan Hour, Yi-Zih Kuo, Guang-Yan Liu, et al.
Plos One|April 16, 2015
Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based studyChia-Chu Liu, Hui-Min Hsieh, Chia-Fang Wu, et al.
Cancer Genomics & Proteomics|April 24, 2021
PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate CancerShu-Pin Huang, Lih-Chyang Chen, Yei-Tsung Chen, et al.
Cancer Medicine|July 8, 2026
Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based StudyJiun-Hung Geng, Chia-Cheng Yu, Chao-Yuan Huang, et al.
Pageof 45